Tumor Early Detection (TED) Study
The NF1-TED study is still recruiting and is looking for 1000 participants, age 18 and older. This study looks to…
Read MoreThe NF1-TED study is still recruiting and is looking for 1000 participants, age 18 and older. This study looks to…
Read MoreIf you or your child has NF1 and have not visited an NF Clinic Network (NFCN) clinic in the past…
Read MorePress Release FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Applicationfor Mirdametinib for the Treatment of Adults and Children…
Read MoreThere’s some exciting news for those with NF2-related schwannomatosis (NF2-SWN) that might bring hope to treatment options! A recent study…
Read MoreFebruary 6th and 7th, NF Midwest staff and volunteers will be meeting with our the offices of our Senators and…
Read MoreAn article by Sharon Reynolds from the National Cancer Institue highlights the importance of people with neurofibromatosis type 1(NF1) to…
Read MoreResearchers at Massachusetts General Hospital are investigating a new stress and symptom management program for adolescents (ages 12-17) with NF1,…
Read MoreResearchers are looking for at least 1,000 people over the age of 40 with NF1 to participate in an exciting…
Read MoreIf you struggle with pain from NF1, you are invited to participate in a clinical trial to evaluate a chronic…
Read MoreOnline Harvard study to help teens learn Stress and Symptom Management Skills NOTE: PLEASE CONTACT THE RESEARCHERS DIRECTLY TO PARTICIPATE-NF…
Read More
© 2024 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.